BCTXL
BriaCell Therapeutics Corp.
Key Financials
Net Income
$-26311867
↓ 449.1%
Operating Income
$-27204803
↑ 18.4%
Total Assets
$21.6M
↑ 268.7%
Cash & Equivalents
$10.5M
↑ 1117.3%
Shareholders' Equity
$-3777181.00
↓ 136.6%
EPS (Diluted)
$-62.19
↓ 21344.8%
Operating Cash Flow
$-28170520.00
↓ 16.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BCTXL |
| Company Name | BriaCell Therapeutics Corp. |
| CIK | 1610820 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0731 |
| State of Incorporation | A1 |
| Phone | (604) 921-1810 |